Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 16 Source: CRO
- €245.1 million turnover
-
€80.2 million
profit - 177 employees
-
31st Dec 15 Source: CRO
- €197.5 million turnover
-
€63.7 million
profit - 176 employees
- 5 more years available »
Ranking
By Turnover
(€245.1 million)- 267th in Top Companies
- 37th in Pharma
By Employees
(177)- 592nd in Top Companies
- 55th in Pharma
-
- 177
- €245.1 million
Employees
- Padraig Summers CEO/Managing Director
Latest News
- 6:48pm Ryanair claims it could lose €5m a year due to ‘peculiar’ Irish tax provision
- 6:44pm Dublin-headquartered Q3 Medical to raise €50m, plans Hong Kong IPO
- 6:35pm European shares lose ground amid concerns over global economic growth
- 6:12pm Man fired over alleged inappropriate remark was reinstated and fired again, court told
- 6:05pm Irish Ferries ‘unlikely’ to operate Rosslare-France route in 2019